Hadasit Bio-Holdings Ltd
Share · IL0010954050 (OTC)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Hadasit Bio-Holdings Ltd
No Price
Company Profile for Hadasit Bio-Holdings Ltd Share
Hadasit Bio-Holdings Ltd operates in the biotechnology industry in Israel. It primarily focuses on the therapeutic areas, including oncology, regenerative medicine, and inflammatory disease. The company offers ProtAb, an immunotherapeutic monoclonal antibody for the treatment of autoimmune inflammatory diseases. Hadasit Bio-Holdings Ltd was founded in 2005 and is based in Jerusalem, Israel.
Company Data
Name Hadasit Bio-Holdings Ltd
Company Hadasit Bio-Holdings Ltd
Website
https://www.hbl.co.il
Primary Exchange 
UTC
UTC
ISIN IL0010954050
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Yuval Adar
Country Israel
Currency USD
Employees 0,0 T
Address Jerusalem Bio-Park, 91120 Jerusalem
IPO Date 2010-10-27
Dividends from 'Hadasit Bio-Holdings Ltd'
| Ex-Date | Dividend per Share |
|---|---|
| 06.02.2019 | 0,59 ILS |
| 07.02.2019 | 0,16 USD |
Stock Splits
| Date | Split |
|---|---|
| 20.12.2017 | 1039:1000 |
| 11.08.2016 | 1:10 |
| 25.07.2016 | 1:10 |
| 08.06.2015 | 1:5 |
| 23.12.2009 | 833:500 |
Ticker Symbols
| Name | Symbol |
|---|---|
| Over The Counter | HSITF |
More Shares
Investors who hold Hadasit Bio-Holdings Ltd also have the following shares in their portfolio:
